Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. (Q52128193)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2001

Language	Label	Description	Also known as
English	Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.	scientific article published in October 2001

Statements

scholarly article

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. (English)

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

amyotrophic lateral sclerosis

0 references

0 references

quality of life

1 reference

based on heuristic

inferred from title

Gian Domenico Borasio

3

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

author name string

Neudert C

1

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

Wasner M

2

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

publication date

1 October 2001

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

191

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

103-109

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

1-2

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

Critical review of the international assessments of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The quality of mercy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Amyotrophic lateral sclerosis: lessons in trial design from recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Palliative care in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in hospice patients. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Development of a direct weighting procedure for quality of life domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life assessment in daily clinical oncology practice: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Redefining health: living with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Development of measurement techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in cancer patients. Who measures what?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in ALS is maintained as physical function declines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in ALS depends on factors other than strength and physical function.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Who should measure quality of life, the doctor or the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality-of-life measurement in advanced cancer: assessing the individual.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Identifiers

10.1016/S0022-510X(01)00612-8

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

1 reference

Europe PubMed Central

22 April 2018

http://europepmc.org/abstract/MED/11676999

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52128193&oldid=1775917172"